Related Experiment Video
Updated: May 23, 2026

09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Using Ascertainment for Targeted Resequencing to Increase Power to Identify Causal Variants
M D Swartz1, B Peng, C Reyes-Gibby
1Division of Biostatistics, The University of Texas Health Science Center at Houston (UT Health), School of Public Health, Houston, TX 77030.
Summary
This study introduces a new method for genetic research using targeted resequencing. By selecting cases with specific risk alleles, the approach significantly boosts the power to identify causal single-nucleotide polymorphisms (SNPs) linked to disease.
Area of Science:
- Genetics
- Genomic Epidemiology
- Biostatistics
Background:
- Genome-wide association studies (GWAS) are crucial for identifying genetic disease markers.
- Current GWAS methods often involve a three-stage analysis, including targeted resequencing to find causal single-nucleotide polymorphisms (SNPs).
Purpose of the Study:
- To propose an enhanced design for targeted resequencing in genetic studies.
- To increase the statistical power for detecting causal variants associated with diseases.
Main Methods:
- Developed a novel ascertainment scheme for targeted resequencing.
- Simulated a disease model with a single causal SNP.
- Compared the proposed method against traditional random selection for resequencing.
Main Results:
- The proposed ascertainment strategy significantly increased the power to detect causal SNPs.
- The method demonstrated a substantial increase in power without elevating the false-positive rate.
- Ascertaining individuals based on risk allele presence proved more effective than random selection.
Conclusions:
- The novel ascertainment scheme enhances the efficiency of targeted resequencing in genetic association studies.
- This approach offers a powerful tool for identifying disease-associated genetic variants.
- The findings suggest a more effective strategy for pinpointing causal SNPs in complex diseases.

